Goss Wealth Management »

Stoke Therapeutics shares owned by Goss Wealth Management

Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Goss Wealth Management from 13F filings

Historical chart of Goss Wealth Management investment in Stoke Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Stoke Therapeutics held by Goss Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stoke Therapeutics by Goss Wealth Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $330k 10k 31.74
2022-12-31 $692 75 9.23

More positions owned by Goss Wealth Management

Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Ishares Core MF Closed and MF Open (IVV)
Amazon Common Stock (AMZN)
Jpmorgan Chase Common Stock (JPM)
Alphabet Common Stock (GOOGL)
Broadcom Common Stock (AVGO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
SPDR S&P MF Closed and MF Open (SPY)
Walmart Common Stock (WMT)
Berkshire Hathaway Common Stock (BRK.B)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Meta Platforms Common Stock (META)
Visa Common Stock (V)

View all positions for Goss Wealth Management

Top funds holding Stoke Therapeutics

FMR
Rtw Investments
Lynx1 Capital Management
BlackRock
Baker Bros. Advisors
Redmile Group
Toronto-Dominion Bank
Vanguard Group
State Street Corporation
Skorpios Trust
Siren
Deerfield Management Company
BVF
Polar Capital Holdings
Assenagon Asset Management

View all funds holding Stoke Therapeutics